Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and pharmacological composition for the diagnosis and treatment of male

a pharmacological composition and male technology, applied in the field of methods and pharmacological compositions, can solve the problems of significant proportion of patients exhibiting unexplained sub-fertility, and achieve the effects of reducing sperm quality, improving semen quality and fertility potential

Inactive Publication Date: 2011-02-10
PERINESS LTD
View PDF19 Cites 27 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention is based on the discovery that high levels of cell-free deoxyoligonucleotides in men's blood circulation are associated with sub-fertility and that blocking the effect of these molecules on sperm cells can improve semen quality and fertility potential. The invention provides a pharmaceutical composition for treating male sub-fertility by either blocking the effect of cell-free DNA or inducing the production of an endogenous substance that blocks its effect. The composition can be a protein, such as a deoxyribonuclease, or a molecule that interferes with the ability of deoxyribonucleic acid molecule to bind to receptors at the surface of sperm cells. The invention also provides a method for treating male sub-fertility by administering the pharmaceutical composition."

Problems solved by technology

Routine semen analysis, however, has many limitations resulting in a significant proportion of patients exhibiting unexplained sub-fertility.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and pharmacological composition for the diagnosis and treatment of male
  • Method and pharmacological composition for the diagnosis and treatment of male
  • Method and pharmacological composition for the diagnosis and treatment of male

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Materials

Standard DNA Solution:

[0121]100 mM calf thymus DNA was dissolved in double distilled water (DDW).

DPA Solution:

[0122]1.5 gr of Diphenylamine was dissolved in 100 ml glacial acetic acid and 1.5 ml sulfuric acid was added. On the day of use, 0.5 ml of acetaldehyde was added.

Polyvinyl Pyrrolidone (PVP) Solution:

[0123]PVP medium 10890001 obtained from Medi-Cult.

Kunitz DNase Activity Reaction Buffer:

[0124]5 mM MgSO4×7H2O, 0.1 M NaAcetate pH 5, 4 mg % Calf thymus DNA

Methods

DNA and Deoxyoligonucleotide Levels (Burton Method):

[0125]Standard DNA solution was diluted to 5, 10, 20 and 50 μg / ml in 166 μl. To each 166 μl of plasma samples or DNA standard sample, 166 μl of 1N HClO4 and 664 μl of DPA solution were added. Samples were incubated at 37° C. for 20 h, and then centrifuged for 10 min (15,000 g, 37° C.). 300 μl of the supernatant was transferred to a 96 well plate an measured in a spectrophotometer at 600 nm.

Semen Volume, Sperm Density and Sperm Concentration:

[0126]The volume of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

Pharmaceutical compositions for treating male sub-fertility that include an agent that causes a reduction in an effect of extracellular DNA on sperm cells, are provided. The agent may be, for example, an enzyme that degrades DNA such as DNase, a substance that blocks the interaction between cell free DNA and sperm cell surface receptors, a substance that binds to DNA, a substance that inhibits endogenous sperm cell DNase, a substance that inhibits a member of a signal transduction pathway mediated by DNA binding to sperm cell surface receptors, or an agent that stimulates production of an endogenous substance that causes a reduction in an antifertility effect of cell free DNA on sperm cells. Also provided are methods for treating male sub-fertility by administering the pharmaceutical composition to a subject in need thereof. Further provided are methods for determining a fertility status in a male subject, methods for assisted reproduction, methods for selecting an assisted reproduction technique (ART), and methods for selecting sperm cells in a sperm cell population for use in an assisted reproduction technique.

Description

FIELD OF THE INVENTION[0001]The invention relates to methods and pharmacological compositions, and more specifically to such methods and pharmacological compositions for use in diagnosing and treating male sub-fertility.LIST OF PRIOR ART[0002]The following is a list of prior art references which are considered to be pertinent for understanding the invention. Acknowledgement of these references herein will at times be made by indicating their number from the list below within parentheses.[0003]1. Isidori A, Latini M, Romanelli F. (1) Isidori A, Latini M, Romanelli F. Treatment of male infertility. Contraception. 2005 October; 72(4):314-8.[0004]2. Kerin J F P, Peek J, Warms G M, Kirby C, Jeffrey R, Matthews C D, Cox L W (1984) Improved conception rate after intrauterine insemination of washed spermatozoa from men with poor quality semen. Lancet 1:533-534.[0005]3. Ombelet W, Puttemans P, Bosmans E (1995) Intrauterine insemination: a first step procedure in the algorithm of male subfert...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/46A61K38/14A61K31/194G01N33/566C12Q1/44G01N33/53A61P15/08A61B17/43
CPCA61K31/00A61K31/194A61K38/46G01N33/689Y10T436/143333G01N2510/00A61K38/14A61K38/1709A61K38/465G01N2333/922C12Y301/21001A61P15/08
Inventor BARTOOV, BENJAMINYEHUDA, RONENDOBROSLAV, MELAMED
Owner PERINESS LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com